Release Date: 25/05/09 16:03 Summary: Final Director's Interest Notice x 3 Price Sensitive: No Download Document 30.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%